GEN
Gen Digital Inc. NMS · GEN
$26.74
-0.27
(-1.00%)
Extended · +1.08σ
Grade C
Price alert —
Loading…
Sign in to get a one-time email the moment GEN crosses your price. Free accounts included.
Sign in / create a free account
Gen Reports Strong Q3 FY26 Results and Raises FY26 Guidance
Benzinga
·
163d ago
Former LifeLock Leader Steve Blackford Joins PrivacyHawk as Chief Marketing Officer
GlobeNewswire Inc.
·
236d ago
3 Oversold Large-Caps That Look Ripe for a Rebound
Investing.com
·
270d ago
Reklaim Hires Former Norton President to Lead Reklaim Protect
Benzinga
·
277d ago
Quantum Computing Could Break the Internet. Some Are Already Building the Fix
Benzinga
·
332d ago
MoneyLion Inc. Stockholders Approve Proposed Acquisition by Gen Digital Inc.
Benzinga
·
464d ago
3 Top Cybersecurity Stock Picks for 2025
Investing.com
·
586d ago
Completion of Share Buy-back Program
GlobeNewswire Inc.
·
751d ago
EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
GlobeNewswire Inc.
·
752d ago
GEN vs. TT: Which Stock Is the Better Value Option?
Zacks Investment Research
·
765d ago
Grant of Restricted Stock Units and Warrants to Employees in Genmab
GlobeNewswire Inc.
·
766d ago
Gen Digital (GEN) is a Top-Ranked Growth Stock: Should You Buy?
Zacks Investment Research
·
766d ago
Are Business Services Stocks Lagging Inter & Co. Inc. (INTR) This Year?
Zacks Investment Research
·
766d ago
Interpublic (IPG) Gains From Buyouts, Client Concentration
Zacks Investment Research
·
767d ago
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks Investment Research
·
767d ago
Time to Buy the Surge in CrowdStrike's (CRWD) Stock After Earnings?
Zacks Investment Research
·
773d ago
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire Inc.
·
773d ago
Zacks.com featured highlights include The Greenbrier, Gen Digital, Leidos, Cabot and Brady
Zacks Investment Research
·
773d ago